STERIS plc stock gains on fresh earnings momentum

Published on 09/08/2026 at 23:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

STERIS plc stock is supported by a 7% revenue increase in fiscal 2027 first-quarter results and a recent NYSE quote near its 52-week range.

Fotorealistische Sterilisationsabteilung mit Autoklav und Instrumententabletts im Krankenhaus — Steris plc IE00BFY8C754 zeigt fotorealistisch eine moderne Krankenhaus-Sterilisationsabteilung mit Edelstahl-Autoklaven und Instrumentenwagen, Illustration mit AI erstellt.

STERIS plc stock (IE00BFY8C754) traded at USD 224.59 on September 4, 2026, after a 0.69 percent decline, while the same session showed a 52-week range of USD 195.14 to USD 269.44 and volume of 468.17K shares.Robinhood The move sits against fiscal 2027 first-quarter revenue of USD 1.50 billion, up 7 percent year over year, and constant-currency organic revenue growth of 6 percent, both reported for the quarter ended June 30, 2026.Backpack Securities

Fiscal Q1 drives the tone

The core comparison is clear: revenue rose from USD 1.4 billion in the first quarter of fiscal 2026 to USD 1.50 billion in the first quarter of fiscal 2027, while quarterly earnings came in at USD 2.59 per share versus a consensus of USD 2.54 per share.Backpack Securities That is a USD 0.05 per share beat, and it gives the latest report more weight than the modest daily stock move alone.

Price stays inside the band

On September 8, 2026, market data put the stock at USD 224.59, which was 1.4 percent above the day's low of USD 221.44 and 0.4 percent below the high of USD 225.44.Robinhood Market capitalization stood at USD 21.9 billion, and the stock's one-year band of USD 195.14 to USD 269.44 leaves it trading in the middle of that range.Robinhood

What the quarter says

The latest quarter also showed the operating mix behind the headline revenue number: constant-currency organic revenue growth was 6 percent, a useful gauge for investors watching how much of the top-line gain came from underlying demand rather than price or currency effects.Backpack Securities With earnings per share at USD 2.59 and revenue at USD 1.50 billion, the company delivered a clean current-period pair of figures that can still be compared directly with the prior-year quarter.

Surgical devices remain central

STERIS plc's product base remains tied to medical devices and sterilization systems, which is why quarterly volume trends and organic growth matter more than broad market sentiment alone. The latest quarter's 6 percent constant-currency organic growth points to continued demand in that core business.Backpack Securities

Stock after the report

STERIS plc stock traded at USD 224.59 on September 4, 2026, with a market cap of USD 21.9 billion and a 52-week range of USD 195.14 to USD 269.44.Robinhood